HOME Top Market Reports Clinical Trial Imaging Market by Modality (CT, MRI, PET, Ultrasound, Echocardiography, X-rays), End User (Pharmaceutical Companies, CROs Medical device Manufacturers), Product (Services, software), and Region - Global Forecast to 2020

Clinical Trial Imaging Market by Modality (CT, MRI, PET, Ultrasound, Echocardiography, X-rays), End User (Pharmaceutical Companies, CROs Medical device Manufacturers), Product (Services, software), and Region - Global Forecast to 2020

By: marketsandmarkets.com
Publishing Date: September 2015
Report Code: HIT 3751

Discount on Reports  

  Speak to Analyst Enquiry Before Buying  
purchase report
download pdf  request for customisation


The global clinical trial imaging market is expected to USD 981.53 Million by 2020 from USD 724.87 Million in 2015, at a CAGR of 6.25% between 2015 and 2020. Clinical imaging is the technique and process used to create images of the human body for clinical purposes to reveal, diagnose or examine diseases including study of normal anatomy and physiology. Clinical trial imaging use has rapidly increased in all phases of the clinical trial. This market report studies the potential of services, and software for diagnostic imaging and research and development.

The major drivers for the market include the growth in pharmaceutical & biotechnology industries, increase in R&D funding and increasing number of CROs are driving the growth of the clinical trial imaging market. On the other hand high implementation cost of imaging systems are the major factors restraining the growth of this market.

This report segments the global market by product, modality, end-user, and geography. By product, the market includes services & software. The services segment is further divided into operational imaging services, systems & technology, reader services & design consulting. The modality segment includes CT, MRI, ultrasound, PET, X-rays, ECHO ad other modalities. The end-user segments included in this report are pharmaceutical companies, biotechnology companies, medical device companies/manufacturers, CROs & academic and government research institutes.

Geographic analysis reveals that North America accounted for the largest share of the global clinical trial imaging market in 2015. Growth in this market can be attributed to the increase in growth of pharmaceutical & biotechnology companies. The Asian regional segment, on the other hand, is expected to register a double-digit growth from 2015 to 2020, owing to the expansion of leading companies and increased R&D spending. R&D spending in Asia increased from $177 billion in 2003 to $329 billion in 2010, at a CAGR of 9.29%. The R&D spending in Asia accounted for 27.13% of global R&D expenditure in 2010.

The major players in this market include BioClinica, Inc. (U.S.), Biomedical Systems (U.S.), Cardiovascular Imaging Technologies (U.S.), ICON Public Limited Company (Ireland), Intrinsic Imaging, LLC (U.S.), IXICO, PLC (U.K.), PAREXEL International Corporation (U.S.), Radiant Sage, LLC (U.S.), VirtualScopic, Inc. (U.S.), and WorldCare Clinical, LLC (U.S.).

Scope of the Report

This research report categorizes the global clinical trial imaging market into the following segments and subsegments:

Global Clinical Trial Imaging Market, by Product

  • Services
  • Operational Imaging Services
  • Reader Services
  • System & Technology
  • Design Consulting
  • Software

Global Clinical Trial Imaging Market, by Modality

  • CT
  • MRI
  • Ultrasound
  • PET
  • X-Rays
  • ECHO
  • Other Modalities

Global Clinical Trial Imaging Market, by End-User

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Medical Device Companies/Manufacturers
  • CROs
  • Academic & Government Research Institutes
  • Other End-Users

Global Clinical Trial Imaging Market, by Geography

  • North America
  • Europe
  • Asia
  • Rest of the World

Table of Contents

1 Introduction (Page No. - 8)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered in the Report
    1.4 Currency
    1.5 Limitation
    1.6 Stakeholders

2 Research Methodology (Page No. - 11)
    2.1 Market Size Estimation
    2.2 Market Breakdown and Data Triangulation
    2.3 Market Share Estimation
           2.3.1 Key Data From Secondary Sources
           2.3.2 Key Data From Primary Sources
           2.3.3 Assumptions for the Study

3 Executive Summary (Page No. - 18)

4 Premium Insights (Page No. - 23)
    4.1Market Overview
    4.2 Life Cycle Analysis, By Region

5 Market Overview (Page No. - 26)
    5.1 Introduction
    5.2 Market Segmentation
           5.2.1 By Product
           5.2.2 By Modality
           5.2.3 By End User
    5.3 Market Dynamics
           5.3.1 Drivers
                    5.3.1.1 Increase in R&D Spending
                    5.3.1.2 Growth in the Pharmaceutical and Biotechnology Industries
                    5.3.1.3 Increasing Number of Cros
           5.3.2 Restraints
                    5.3.2.1 High Implementation Cost of Imaging Systems
           5.3.3 Opportunities
                    5.3.3.1 Emerging Economies
                    5.3.3.2 Development of Innovative Imaging Modalities, Contrast Agents, Molecular Probes, & Radiopharmaceuticals
           5.3.4 Challenges
                    5.3.4.1 High Cost of Clinical Trials
                    5.3.4.2 High Cost of Pet
           5.3.5 Trends
                    5.3.5.1 Rising Demand for Multimodality Imaging Technology in Clinical Trials

6 Clinical Trial Imaging Market, By Product (Page No. - 35)
    6.1 Introduction
    6.2 Services
           6.2.1 Operational Imaging Services
           6.2.2 Read Analysis Services
           6.2.3 System and Technical Support Services
           6.2.4 Trial Design Consulting Services
    6.3 Software

7 Clinical Trial Imaging Market, By Modality (Page No. - 49)
    7.1 Introduction
    7.2 Computed Tomography
    7.3 Magnetic Resonance Imaging
    7.4 Ultrasound
    7.5 Positron Emission Tomography
    7.6 X-Ray
    7.7 Echocardiography
    7.8 Other Modalities

8 Clinical Trial Imaging Market, By End User (Page No. - 64)
    8.1 Introduction
    8.2 Pharmaceutical Companies
    8.3 Biotechnology Companies
    8.4 Medical Device Manufacturers
    8.5 Contract Research Organizations
    8.6 Academic and Government Research Institutes
    8.7 Other End Users

9 Geographic Analysis (Page No. - 79)
    9.1 Introduction
    9.2 North America
    9.3 Europe
    9.4 Asia
    9.5 Rest of the World (RoW)

10 Competitive Landscape (Page No. - 106)
     10.1 Introduction
     10.2 Strategic Overview
     10.3 Leading Players in the Market
     10.4 Competitive Situation and Trends
             10.4.1 Agreements, Collaborations, and Partnerships
             10.4.2 Acquisitions
             10.4.3 New Product and Service Launches & Product Upgrades
             10.4.4 Expansions
             10.4.5 Other Developments

11 Company Profiles (Page No. - 115)
     11.1 Introduction
     11.2 Bioclinica, Inc.
             11.2.1 Business Overview
             11.2.2 Services Offered
             11.2.3 Recent Developments
             11.2.4 MnM View
     11.3 Parexel International Corporation
             11.3.1 Business Overview
             11.3.2 Services Offered
             11.3.3 Recent Developments
             11.3.4 MnM View
                        11.3.4.1 Financial Analysis
                        11.3.4.2 Strategic Analysis
     11.4 Icon Public Limited Company
             11.4.1 Business Overview
             11.4.2 Services Offered
             11.4.3 Recent Developments
             11.4.4 MnM View
                        11.4.4.1 Financial Analysis
                        11.4.4.2 Strategic Analysis
     11.5 Biomedical Systems Corporation
             11.5.1 Business Overview
             11.5.2 Services Offered
             11.5.3 Recent Developments
             11.5.4 MnM View
     11.6 Virtualscopics, Inc.
             11.6.1 Business Overview
             11.6.2 Services Offered
             11.6.3 Recent Development
             11.6.4 MnM View
                        11.6.4.1 Financial Analysis
                        11.6.4.2 Strategic Analysis
     11.7 Cardiovascular Imaging Technologies, LLC
             11.7.1 Business Overview
             11.7.2 Products & Services Offered
     11.8 Intrinsic Imaging LLC
             11.8.1 Business Overview
             11.8.2 Services Offered
             11.8.3 Recent Developments
     11.9 Ixico PLC
             11.9.1 Business Overview
             11.9.2 Products & Services Offered
             11.9.3 Recent Developments
     11.10 Radiant Sage LLC
             11.10.1 Business Overview
             11.10.2 Products & Services Offered
             11.10.3 Recent Developments
     11.11 Worldcare Clinical, LLC
             11.11.1 Business Overview
             11.11.2 Services Offered
             11.11.3 Recent Developments

12 Appendix (Page No. - 136)
     12.1 Insights of Industry Experts
     12.2 Discussion Guide
     12.3 Other Developments
     12.4 Introducing RT: Real-Time Market Intelligence
     12.5 Available Customizations
     12.6 Related Reports


List of Tables (73 Tables)

Table 1 Market Summary
Table 2 Increase in R&D Spending is Propelling the Growth of the Market
Table 3 High Implementation Cost of Imaging Systems to Restrain Market Growth
Table 4 Emerging Economies Offer Significant Growth Opportunities
Table 5 High Cost of Clinical Trials Pose A Challenge for the Market
Table 6 Rising Demand for Multimodality Imaging Technology in Clinical Trials is A Major Trend Observed in This Market
Table 7 Clinical Trial Imaging Market Size, By Product, 2013–2020 (USD Million)
Table 8 Clinical Trial Imaging Services Market Size, By Type, 2013–2020 (USD Million)
Table 9 Clinical Trial Imaging Services Market Size, By Region, 2013–2020 (USD Million)
Table 10 North America: Clinical Trial Imaging Services Market Size, By Country, 2013–2020 (USD Million)
Table 11 Clinical Trial Imaging Market Size for Operational Imaging Services, By Region, 2013–2020 (USD Million)
Table 12 North America: Market Size for Operational Imaging Services, By Country, 2013–2020 (USD Million)
Table 13 Clinical Trial Imaging Market Size for Read Analysis Services, By Region, 2013–2020 (USD Million)
Table 14 North America: Market Size for Read Analysis Services, By Country, 2013–2020 (USD Million)
Table 15 Market Size for System and Technical Support Services, By Region, 2013–2020 (USD Million)
Table 16 North America: Market Size for System and Technical Support Services, By Country, 2013–2020 (USD Million)
Table 17 Market Size for Trial Design Consulting Services, By Region, 2013–2020 (USD Million)
Table 18 North America: Market Size for Trial Design Consulting Services, By Country, 2013–2020 (USD Million)
Table 19 Software Market Size, By Region, 2013–2020 (USD Million)
Table 20 North America: Software Market Size, By Country, 2013–2020 (USD Million)
Table 21 Market Size, By Modality, 2013–2020 (USD Million)
Table 22 Market Size for CT, By Region, 2013–2020 (USD Million)
Table 23 North America: Market Size for CT, By Country, 2013–2020 (USD Million)
Table 24 Market Size for Mri, By Region, 2013–2020 (USD Million)
Table 25 North America: Market Size for Mri, By Country, 2013–2020 (USD Million)
Table 26 Market Size for Ultrasound, By Region, 2013–2020 (USD Million)
Table 27 North America: Market Size for Ultrasound, By Country, 2013–2020 (USD Million)
Table 28 Market Size for Pet, By Region, 2013–2020 (USD Million)
Table 29 North America: Market Size for Pet, By Country, 2013–2020 (USD Million)
Table 30 Market Size for X-Ray, By Region, 2013–2020 (USD Million)
Table 31 North America: Market Size for X-Ray, By Country, 2013–2020 (USD Million)
Table 32 Market Size for Echocardiography, By Region, 2013–2020 (USD Million)
Table 33 North America: Market Size for Echocardiography, By Country, 2013–2020 (USD Million)
Table 34 Clinical Trial Imaging Market Size for Other Modalities, By Region, 2013–2020 (USD Million)
Table 35 North America: Market Size for Other Modalities, By Country, 2013–2020 (USD Million)
Table 36 Market Size, By End User, 2013–2020 (USD Million)
Table 37 Market Size for Pharmaceutical Companies, By Region, 2013–2020 (USD Million)
Table 38 North America: Market Size for Pharmaceutical Companies, By Country, 2013–2020 (USD Million)
Table 39 Market Size for Biotechnology Companies, By Region, 2013–2020 (USD Million)
Table 40 North America: Market Size for Biotechnology Companies, By Country, 2013–2020 (USD Million)
Table 41 Market Size for Medical Device Manufacturers, By Region, 2013–2020 (USD Million)
Table 42 North America: Market Size for Medical Device Manufacturers, By Country, 2013–2020 (USD Million)
Table 43 Market Size for Cros, By Region, 2013–2020 (USD Million)
Table 44 North America: Market Size for Cros, By Country, 2013–2020 (USD Million)
Table 45 Clinical Trial Imaging Market Size for Academic and Government Research Institutes, By Region, 2013–2020 (USD Million)
Table 46 North America: Market Size for Academic and Government Research Institutes, By Country, 2013–2020 (USD Million)
Table 47 Market Size for Other End Users, By Region, 2013–2020 (USD Million)
Table 48 North America: Market Size for Other End Users, By Country, 2013–2020 (USD Million)
Table 49 Market Size, By Region, 2013–2020 (USD Million)
Table 50 North America: Market Size, By Country, 2013–2020 (USD Million)
Table 51 North America: Market Size, By Product, 2013–2020 (USD Million)
Table 52 North America: Clinical Trial Imaging Services Market Size, By Type, 2013-2020 (USD Million)
Table 53 North America: Market Size, By Modality, 2013–2020 (USD Million)
Table 54 North America: Market Size, By End User, 2013–2020 (USD Million)
Table 55 Europe: Market Size, By Product, 2013–2020 (USD Million)
Table 56 Europe: Clinical Trial Imaging Services Market Size, By Type, 2013-2020 (USD Million)
Table 57 Europe: Market Size, By Modality, 2013–2020 (USD Million)
Table 58 Europe: Market Size, By End User, 2013–2020 (USD Million)
Table 59 Asia: Market Size, By Product, 2013–2020 (USD Million)
Table 60 Asia: Clinical Trial Imaging Services Market Size, By Type, 2013-2020 (USD Million)
Table 61 Asia: Market Size, By Modality, 2013–2020 (USD Million)
Table 62 Asia: Market Size, By End User, 2013–2020 (USD Million)
Table 63 RoW: Market Size, By Product, 2013–2020 (USD Million)
Table 64 RoW: Clinical Trial Imaging Services Market Size, By Type, 2013-2020 (USD Million)
Table 65 RoW: Market Size, By Modality, 2013–2020 (USD Million)
Table 66 RoW: Market Size, By End User, 2013–2020 (USD Million)
Table 67 Rank of Companies in the Global Clinical Trial Imaging Market, 2015
Table 68 Battle for Market Share: Agreements, Collaborations, and Partnerships Was the Key Strategy Adopted By Players Between January 2013 and August 2015
Table 69 Agreements, Collaborations, and Partnerships, 2013–2015
Table 70 Acquisitions, 2013–2015
Table 71 New Product and Service Launches & Product Upgrades, 2013–2015
Table 72 Expansions, 2013–2015
Table 73 Other Developments, 2013–2015


List of Figures (76 Figures)

Figure 1 Clinical Trial Imaging Market
Figure 2 Research Design
Figure 3 Market Size Estimation Methodology: Bottom-Up Approach
Figure 4 Market Size Estimation Methodology: Top-Down Approach
Figure 5 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 6 Data Triangulation Methodology
Figure 7 Clinical Trial Imaging Market Size, By Product, 2015 vs 2020 (USD Million)
Figure 8 Market Size, By Modality, 2015 vs 2020 (USD Million)
Figure 9 Market Size, By End User, 2015 vs 2020 (USD Million)
Figure 10 Clinical Trial Imaging Market: Geographic Snapshot (2015)
Figure 11 Market Size, By Region, 2015 vs 2020 (USD Million)
Figure 12 Emerging Economies Offer Significant Growth Opportunities for Market Growth
Figure 13 Services Segment to Account for the Largest Market Share in 2015
Figure 14 Asia to Witness Highest Growth Rate in the Forecast Period
Figure 15 North America Market Segment Headed Toward Maturity
Figure 16 Clinical Trial Imaging Market: By Product
Figure 17 Clinical Trial Imaging Market: By Modality
Figure 18 Clinical Trial Imaging Market: By End User
Figure 19 Increase in R&D Spending Will Drive the Market
Figure 20 Increasing R&D Funding Boosting Growth in the Market
Figure 21 Number of Biotechnology Patents, By Country, 2012
Figure 22 Market Segmentation, By Product
Figure 23 Clinical Trial Imaging Services to Form the Largest Segment in 2015
Figure 24 Operational Imaging Services to Form the Largest and Fastest-Growing Segment in the Forecast Period
Figure 25 North America to Command Largest Share of the Clinical Trial Imaging Services Market in 2015
Figure 26 Asia to Be the Fastest-Growing Segment of the Operational Imaging Services Market in the Forecast Period
Figure 27 North America to Form the Largest Segment of the Read Analysis Services Market in 2015
Figure 28 Asia to Form the Fastest-Growing Segment of the System and Technical Support Services Market in the Forecast Period
Figure 29 North America to Command Largest Share of the Trial Design Consulting Services Market in the Forecast Period
Figure 30 Asia to Be the Fastest-Growing Segment of the Clinical Trial Imaging Software Market in the Forecast Period
Figure 31 Market Segmentation, By Modality
Figure 32 CT Segment to Command the Largest Share of the Market in 2015
Figure 33 North America Expected to Dominate the Clinical Trial Imaging Market for CT
Figure 34 Asia to Witness Highest Growth in the Market for Mri in the Forecast Period
Figure 35 North America Expected to Form the Largest Regional Segment for Ultrasound
Figure 36 Asia Expected to Be the Fastest-Growing Regional Segment for Pet Market Between 2015 and 2020
Figure 37 X-Ray Market in Asia to Witness Highest Growth in the Forecast Period
Figure 38 Echocardiography Segment to Witness Highest Growth in Asia
Figure 39 North America Dominates the Market for Other Modalities
Figure 40 Clinical Trial Imaging Market, By End User
Figure 41 Clinical Trial Imaging Market Size, By End User, 2015 (USD Million)
Figure 42 Number of Biotechnology and Pharmaceutical Patents Granted in 2012, By Region
Figure 43 Pharmaceutical Companies Segment to Witness Highest Growth in Asia
Figure 44 North America to Command the Largest Share of the Biotechnology Companies Segment in 2020
Figure 45 North America to Dominate the Market for Medical Device Manufacturers in 2020
Figure 46 North America Expected to Dominate the Market for Cros
Figure 47 Public-Sector Research Funding is Driving the Growth of the Academic & Government Research Institutes End-User Segment
Figure 48 North America Dominates the Market for Academic and Government Research Institutes
Figure 49 Asia to Witness the Highest Growth in the Clinical Trial Imaging Market for Other End Users in the Forecast Period
Figure 50 Clinical Trial Imaging Market, By Region (Market Size and Growth Rate), 2015-2020
Figure 51 Clinical Trial Imaging Market in Asia Expected to Grow at the Highest Rate From 2015 to 2020
Figure 52 North America: Market Snapshot
Figure 53 U.S. Forms the Fastest-Growing Market in North America in 2015
Figure 54 Services are Estimated to Be the Largest Product Segment in North America (2015)
Figure 55 Operational Imaging Largest Services Segment in North America (2015)
Figure 56 CT Expected to Form for the Largest Modality Segment in North America in 2015
Figure 57 Pharmaceutical Companies to Form the Largest End-User Segment in North America in 2015
Figure 58 Services to Form the Largest Product Segment in Europe 2015
Figure 59 Operational Imaging Accounted for the Largest Share in the European Clinical Trial Imaging Market in 2015
Figure 60 CT Segment to Command the Largest Share of the European Clinical Trial Imaging Market in 2015
Figure 61 Pharmaceutical Companies to Form the Largest End-User Segment in Europe in 2015
Figure 62 Asia: Market Snapshot
Figure 63 Services to Form the Largest Product Segment in Asia (2015)
Figure 64 Operational Imaging to Form the Largest Services Segment in Asia in 2015
Figure 65 CT Segment to Account for the Largest Share of the Market in Asia
Figure 66 Pharmaceutical Companies to Form the Largest End-User Segment in Asia in 2015
Figure 67 Services to Form the Largest Product Segment in the RoW in 2015
Figure 68 Operational Imaging to Command the Largest Share in the RoW Clinical Trial Imaging Market (2015)
Figure 69 CT to Form the Largest Modality Segment in RoW in 2015
Figure 70 Pharmaceutical Companies to Form the Largest End-User Segment in RoW in 2015
Figure 71 Agreements, Partnerships, and Collaborations is the Key Growth Strategy Adopted By Players in the Market
Figure 72 Market Developments Between January 2013 and August 2015
Figure 73 Company Snapshot: Parexel International Corporation
Figure 74 Company Snapshot: Icon Public Limited Company
Figure 75 Company Snapshot: Virtualscopics, Inc.
Figure 76 Company Snapshot: Ixico PLC

The global clinical trial imaging market is expected to USD 981.53 Million by 2020 from USD 724.87 Million in 2015, at a CAGR of 6.25% between 2015 and 2020. The major drivers for the market include growth in pharmaceutical & biotechnology industries, increase in R&D funding and increasing number of CROs are driving the growth of the global clinical trials market. The emerging economies in developing countries and development of innovative new imaging modalities, contrast agents, molecular probes & radiopharmaceutical will provide opportunities and new trends for market growth.

The report provides a granular understanding of the clinical trial imaging market. This report segments the global clinical trial imaging market on the basis of products, modalities, end-users, and geographies. The product segments included in this report are services and software.

The modality segment includes CT, MRI, Ultrasound, PET, X-rays, ECHO and other modalities. The end-user segments included in this report are pharmaceutical companies, biotechnology companies, medical device companies/manufacturers, CROs & academic and government research institutes.

The geographic segments included in this report are North America, Europe, Asia, and the Rest of the World (RoW). The report maps each test type and product segment in 11 geographic and regional segments.

The major players in this market include BioClinica, Inc. (U.S.), Biomedical Systems (U.S.), Cardiovascular Imaging Technologies (U.S.), ICON Public Limited Company (Ireland), Intrinsic Imaging, LLC (U.S.), IXICO, PLC (U.K.), PAREXEL International Corporation (U.S.), Radiant Sage, LLC (U.S.), VirtualScopic, Inc. (U.S.), and WorldCare Clinical, LLC (U.S.).

Global clinical trial imaging MARKET snapshot, 2015 (USD Million)

Clinical Trials Imaging Market

Clinical Trials Imaging Market

Clinical Trials Imaging Market

Clinical Trials Imaging Market

Available Customizations Title

Client Consult Problem Statement : MnM’s client was a leading manufacturer of various clinical laboratory products and wanted to enter in African market and was majorly interested in knowing current scenario and understanding various opportunities present in this market. The client was looking for information related to major test types by volume, leading laboratory departments by volume, number of tests performed by leading players, potential countries, major laboratory instrument providers, competitive landscape for leading labs and end-user preferences

Solution Provided:

1. Methodology Adopted by MnM :

The study involved extensive interviews with the Primar....

1. Methodology Adopted by MnM :

The study involved extensive interviews with the Primary respondents from the demand side involving key laboratory personnel for the estimation of the Total Addressable Market (TAM) to understand the current scenario. MnM analyzed current & forecast quantitative market information for the market sizing and forecasted the growth of the Laboratory product market. For understanding the epidemiological aspect of key application areas in all the specified regions data from was gathered from the Laboratories associations and the doctors involved to understand the current trends and processes involved.

2. Actual Solution Provided:

   • Estimation of total addressable market size and forecast (for next 5 years)
   • Regional and Country-wise analysis for 18 major African countries
   • Identification of potential countries by ranking them using various socio-economic parameters
   • Analysis of contribution by public and private sector for each country
   • Analyzing various macro and micro factors impacting market growth
   • Business insights to formulate optimum strategy to grab market opportunity in potential countries

Value Delivered:

After working through the detailed market analysis and end-user market assessment by MnM, client successfully formulated its market entry strategy to in selected African countries to introduce its clinical laboratory products for major laboratories in the region.

less...
Request Customization
 more...
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Pharmaceutical IT Markets on KnowledgeStore
Request Demo